n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Migraine Disorders in 1 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Varga, H | 1 |
| Pardutz, A | 1 |
| Vamos, E | 1 |
| Bohar, Z | 1 |
| Bago, F | 1 |
| Tajti, J | 1 |
| Bari, F | 1 |
| Vecsei, L | 1 |
1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Migraine Disorders
| Article | Year |
|---|---|
Selective inhibition of cyclooxygenase-2 attenuates nitroglycerin-induced calmodulin-dependent protein kinase II alpha in rat trigeminal nucleus caudalis.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cerebral Arteries; Cerebrovascular Circ | 2009 |